tiprankstipranks
Trending News
More News >
Erasca’s Innovative RAS/MAPK Pathway Targeting and Promising Preclinical Data Earns Buy Rating
PremiumRatingsErasca’s Innovative RAS/MAPK Pathway Targeting and Promising Preclinical Data Earns Buy Rating
1M ago
Erasca presents new RAS-targeting franchise data at AACR meeting
Premium
The Fly
Erasca presents new RAS-targeting franchise data at AACR meeting
1M ago
Erasca initiated with an Outperform at Raymond James
Premium
The Fly
Erasca initiated with an Outperform at Raymond James
2M ago
ERAS Earnings this Week: How Will it Perform?
PremiumPre-EarningsERAS Earnings this Week: How Will it Perform?
3M ago
Erasca assumed with an Overweight at Morgan Stanley
Premium
The Fly
Erasca assumed with an Overweight at Morgan Stanley
3M ago
Erasca’s Promising Oncology Advances: Buy Rating Backed by Strong Market Potential and Competitive Edge
Premium
Ratings
Erasca’s Promising Oncology Advances: Buy Rating Backed by Strong Market Potential and Competitive Edge
3M ago
Erasca reports Q3 EPS (11c), consensus (17c)
PremiumThe FlyErasca reports Q3 EPS (11c), consensus (17c)
7M ago
Erasca announces clinical progress for naporafenib
Premium
The Fly
Erasca announces clinical progress for naporafenib
8M ago
Erasca to present preliminary SEACRAFT-1 Phase 1 data
Premium
The Fly
Erasca to present preliminary SEACRAFT-1 Phase 1 data
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100